SlideShare ist ein Scribd-Unternehmen logo
1 von 20
Secondary[Acquired]
Immunodeficiency states
 may arise as complications of :-
  infections ; malnutrition ; aging ; or side effects of
  immunosuppression, irradiation , chemotherapy.

Acquired Immunodeficiency Syndrome (AIDS) :
 caused by retrovirus Human Immunodeficiency Virus
  (HIV).
 characterized by profound immunosuppression that
  leads to opportunistic infections, secondary neoplasms,
  and neurologic manifestations.
 The virus is transmited via:
  1. Unprotected sex with someone who is infected.
  2. Transfusion of contaminated blood
     or blood products ; skin grafts or organ transplants
     taken from someone who is infected.
  3. From a mother who is infected to her baby , this
     can occur during pregnancy, at birth , and through
     breast feeding.
 4. Sharing unsterilized injection equipment that has
    previously been used by someone who is infected
    as in drug addicts.
Properties of HIV:
 HIV is retrovirus ( RNA containing virus ) that can
  convert its genetic material into DNA by means of
  enzyme reverse transcriptase which enables it
  to become integrated into DNA of its host cells.
 Two genetically different but related forms of HIV,
  called HIV-1 and HIV-2.
Structure of HIV:
 HIV virion is spherical and contains a cone-shaped core
  surrounded by a lipid envelope derived from the host
  cell membrane .
 The virus core contains:
 (1) major capsid protein ( p24 ).
 (2) nucleocapsid protein ( p7/p9 ).
 (3) two copies of genomic RNA.
 (4) three viral enzymes (protease , reverse transcriptase ,
     and integrase).
 p24 is the most readily detected viral antigen and,
  is the target for antibodies that are used for
  diagnosis of HIV infection.
 The viral core is surrounded by a matrix protein
  called p17, which lies underneath the virion
  envelope.
 Studding the viral envelope are two viral
  glycoproteins ( gp120 and gp41 ) which are critical
  for HIV infection of cells.
HIV- structure
Pathogenesis of HIV Infection and AIDS:
there are two major targets of HIV infection:
immune system and central nervous system.
Immune system:-
 This results from infection and severe loss of
  CD4+ T cells as well as impairment in function
  of surviving CD4+ T cells.
 macrophages and dendritic cells are also targets of
  HIV infection.
 HIV envelope contains two glycoproteins, surface
  ( gp120 ) that is non-covalently attached to
  transmembrane protein ( gp41 ).
 The initial step in infection is binding of gp120.
 This binding leads to a conformational change that
  results in formation of a new recognition site on
  gp120 for coreceptors CCR5 ( on macrophage ) or
  CXCR4 (on CD4+ T cells ).
 The next step involves conformational changes in
  gp41 , these changes result in insertion of a fusion
  peptide at tip of gp41 into cell membrane of target
  cells .
 After fusion, the virus core containing HIV genome
  enters cytoplasm of cell.
 Once internalized, the RNA genome of virus undergoes
  reverse transcription, leading to formation of cDNA
  (proviral DNA) .
 In quiescent T cells, HIV cDNA may remain in cytoplasm.
 In dividing T cells, the cDNA , enters the nucleus and
  is then integrated into host genome.
 After this integration, the provirus may remain locked
  into chromosome for months or years, and hence the
  infection becomes latent.
 Alternatively, proviral DNA may be transcribed, with
  formation of complete viral particles that bud from cell
  membrane.
 Such productive infection, when associated with
  extensive viral budding, leads to cell death.
 Early in course of HIV infection, the immune system
  can replace the dying T cells.
 Later in course of disease, renewal of CD4+ T cells
  cannot keep up with loss of these cells.
 Despite the fact that macrophages allow viral
  replication, they are quite resistant to cytopathic
  effects of HIV, in contrast to CD4+ T cells.
  Thus, macrophages may be reservoirs of infection.
 two types of dendritic cells are also targets of HIV
  infection: mucosal and follicular dendritic cells.
 patients with AIDS also display profound abnormalities
  of B-cell function
Central Nervous System:
 It is a major target of HIV infection.
 Macrophages and microglia (cells in central nervous
  system that belong to monocyte and macrophage
  lineage) are predominant cell types in brain that are
  infected with HIV.
 HIV is carried into brain by infected monocytes.
Natural History of HIV Infection:
Three phases recognized:-
(1) Early , acute retroviral syndrome.
(2) Middle, chronic phase.
(3) Final , full-blown AIDS.
 Early , acute retroviral syndrome ( phase 1):
 high level of virus production, viremia, and
   widespread seeding of lymphoid tissues.
 however, is readily controlled by development
   of antiviral immune response.
 Clinically: nonspecific symptoms, including sore throat,
   myalgia , fever, rash, weight loss, and fatigue,
   resembling a flulike syndrome.
Middle chronic phase ( phase 2 ):
 represents a stage of relative containment of virus,
  associated with period of clinical latency.
 The immune system is largely intact, but there is
  continuous HIV replication, predominantly in lymphoid
  tissues, which may last for several years.
 Patients are either asymptomatic or develop
  persistent generalized lymphadenopathy.
 Final phase ( phase 3 ), full-blown AIDS :
 Its progression to AIDS, characterized by a breakdown
  of host defense, a dramatic increase in plasma virus,
  and clinical disease.
 Typically the patient presents with long-lasting fever
  (>1 month), fatigue, weight loss, and diarrhea.
 After a variable period: serious opportunistic infections,
  secondary neoplasms, or clinical neurologic disease
  (grouped under the AIDS indicator diseases ), and
  the patient is said to have developed AIDS.
Clinical Features of AIDS:
 Opportunistic infections:
 account for the majority of deaths in patients with
   AIDS.
 Approximately 15% to 30% of HIV-infected people
   develop pneumonia caused by opportunistic fungus
   P. carinii .The risk of developing this infection is
   extremely high in individuals with fewer than
   200 CD4+ cells/µL.
 other opportunistic infections are caused by Candida,
   cytomegalovirus, atypical and typical mycobacteria,
   Cryptococcus neoformans, Toxoplasma gondii, and
   herpes simplex virus.
 Neoplasms :
 Kaposi sarcoma (KS) ; non-Hodgkin B-cell lymphoma ;
  cervical cancer in women ; and anal cancer in men.
 It is estimated that 25% to 40% of HIV-infected
  individuals will eventually develop malignancy.
 KS is composed of mesenchymal (spindle) cells that
  form blood vessels; the proliferation of these cells is
  driven by a variety of cytokines and growth factors that
  are derived from tumor cells , and from HIV-infected
  T cells. it is strongly linked to infection of tumor cells
  by KS-associated herpesvirus (KSHV).
 Central nervous system:
 90%of patients demonstrate some form of neurologic
  involvement at autopsy ; and 40% to 60% have
  clinically manifest neurologic dysfunction.
 These include : self-limited meningoencephalitis ;
  aseptic meningitis ; vacuolar myelopathy ;
  peripheral neuropathies ; and most commonly
  a progressive encephalopathy designated clinically
  as (AIDS-dementia complex ).
Morphology:
 Biopsy specimens from enlarged lymph nodes in
  early stages of HIV infection reveal marked follicular
  hyperplasia.
 With disease progression, B-cell proliferation subsides
  and gives rise to severe follicular involution.
  The follicles are depleted of cells.
  The germinal centers may become hyalinized.
  These lymph nodes are atrophic and small and
  may harbor numerous opportunistic pathogens.
 Lymphoid depletion is not confined to lymph nodes;
  in later stages of AIDS, the spleen and thymus also
  appear to be "wastelands."
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Lab diagnosis of fungal infections, Dr Naveen Reddy
Lab diagnosis of fungal infections, Dr Naveen ReddyLab diagnosis of fungal infections, Dr Naveen Reddy
Lab diagnosis of fungal infections, Dr Naveen ReddyNaveen Parvathareddy
 
Diseases of the Immune System
Diseases of the Immune SystemDiseases of the Immune System
Diseases of the Immune SystemGhie Santos
 
Candidiasis – clinical manifestations and lab diagnosis of oral candidiasis
Candidiasis – clinical manifestations and lab diagnosis of oral candidiasisCandidiasis – clinical manifestations and lab diagnosis of oral candidiasis
Candidiasis – clinical manifestations and lab diagnosis of oral candidiasisShiv Joshi
 
LABORATORY DIAGNOSIS OF VIRAL INFECTION.pptx
LABORATORY DIAGNOSIS OF VIRAL INFECTION.pptxLABORATORY DIAGNOSIS OF VIRAL INFECTION.pptx
LABORATORY DIAGNOSIS OF VIRAL INFECTION.pptxDR ABHISHEK JAIN
 
Haemophilus mahadi ppt
Haemophilus mahadi pptHaemophilus mahadi ppt
Haemophilus mahadi pptMahadi Mahmoud
 
laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)PathKind Labs
 
Leukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reactionLeukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reactionSindhuja Yella
 
Hepatitis b virus general virology and laboratory diagnosis
Hepatitis b virus  general virology and laboratory diagnosisHepatitis b virus  general virology and laboratory diagnosis
Hepatitis b virus general virology and laboratory diagnosisShyam Mishra
 
Arenaviruses
ArenavirusesArenaviruses
ArenavirusesPrenesh
 
HIV pathology sufia husain 2017
HIV pathology sufia husain 2017HIV pathology sufia husain 2017
HIV pathology sufia husain 2017Sufia Husain
 
laboratory diagnosis of fungal inections
laboratory diagnosis of fungal inectionslaboratory diagnosis of fungal inections
laboratory diagnosis of fungal inectionsAditi Kothari
 
Subcutaneous mycoses
Subcutaneous mycosesSubcutaneous mycoses
Subcutaneous mycosessharon_va
 

Was ist angesagt? (20)

Lab diagnosis of fungal infections, Dr Naveen Reddy
Lab diagnosis of fungal infections, Dr Naveen ReddyLab diagnosis of fungal infections, Dr Naveen Reddy
Lab diagnosis of fungal infections, Dr Naveen Reddy
 
Diseases of the Immune System
Diseases of the Immune SystemDiseases of the Immune System
Diseases of the Immune System
 
Clostridium
ClostridiumClostridium
Clostridium
 
Candidiasis – clinical manifestations and lab diagnosis of oral candidiasis
Candidiasis – clinical manifestations and lab diagnosis of oral candidiasisCandidiasis – clinical manifestations and lab diagnosis of oral candidiasis
Candidiasis – clinical manifestations and lab diagnosis of oral candidiasis
 
Histoplasmosis
HistoplasmosisHistoplasmosis
Histoplasmosis
 
LABORATORY DIAGNOSIS OF VIRAL INFECTION.pptx
LABORATORY DIAGNOSIS OF VIRAL INFECTION.pptxLABORATORY DIAGNOSIS OF VIRAL INFECTION.pptx
LABORATORY DIAGNOSIS OF VIRAL INFECTION.pptx
 
Haemophilus mahadi ppt
Haemophilus mahadi pptHaemophilus mahadi ppt
Haemophilus mahadi ppt
 
Inclusion bodies
Inclusion bodiesInclusion bodies
Inclusion bodies
 
laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)
 
Fungal diseases(MYCOSES)
Fungal diseases(MYCOSES)Fungal diseases(MYCOSES)
Fungal diseases(MYCOSES)
 
Superficial mycoses
Superficial mycosesSuperficial mycoses
Superficial mycoses
 
Superficial mycosis
Superficial mycosisSuperficial mycosis
Superficial mycosis
 
Leukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reactionLeukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reaction
 
Hepatitis b virus general virology and laboratory diagnosis
Hepatitis b virus  general virology and laboratory diagnosisHepatitis b virus  general virology and laboratory diagnosis
Hepatitis b virus general virology and laboratory diagnosis
 
Immune Response to HIV
Immune Response to HIVImmune Response to HIV
Immune Response to HIV
 
Arenaviruses
ArenavirusesArenaviruses
Arenaviruses
 
HIV pathology sufia husain 2017
HIV pathology sufia husain 2017HIV pathology sufia husain 2017
HIV pathology sufia husain 2017
 
laboratory diagnosis of fungal inections
laboratory diagnosis of fungal inectionslaboratory diagnosis of fungal inections
laboratory diagnosis of fungal inections
 
Epstein-Barr Virus
Epstein-Barr Virus�Epstein-Barr Virus�
Epstein-Barr Virus
 
Subcutaneous mycoses
Subcutaneous mycosesSubcutaneous mycoses
Subcutaneous mycoses
 

Andere mochten auch

Andere mochten auch (14)

Immunopathology 3
Immunopathology 3Immunopathology 3
Immunopathology 3
 
Immunopathology 6
Immunopathology 6Immunopathology 6
Immunopathology 6
 
Ppt hiv
Ppt hivPpt hiv
Ppt hiv
 
Immunopathology 1
Immunopathology 1Immunopathology 1
Immunopathology 1
 
Immunopathology lecture 2+3 ,final
Immunopathology lecture 2+3 ,finalImmunopathology lecture 2+3 ,final
Immunopathology lecture 2+3 ,final
 
Immune response to hiv infection
Immune response to hiv infectionImmune response to hiv infection
Immune response to hiv infection
 
HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)HIV/AIDS (IMMUNOLOGY)
HIV/AIDS (IMMUNOLOGY)
 
Pathogenesis Hiv Slide
Pathogenesis Hiv SlidePathogenesis Hiv Slide
Pathogenesis Hiv Slide
 
IMMUNOPATHOLOGY
IMMUNOPATHOLOGYIMMUNOPATHOLOGY
IMMUNOPATHOLOGY
 
HIV (AIDS)
 HIV (AIDS) HIV (AIDS)
HIV (AIDS)
 
Immunopathology
ImmunopathologyImmunopathology
Immunopathology
 
HIV infection (AIDS)
HIV infection (AIDS)HIV infection (AIDS)
HIV infection (AIDS)
 
Comprehensive Presentation on HIV/AIDS
Comprehensive Presentation on HIV/AIDSComprehensive Presentation on HIV/AIDS
Comprehensive Presentation on HIV/AIDS
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 

Ähnlich wie Immunopathology 5

Ähnlich wie Immunopathology 5 (20)

15333964-Immunodeficiency-Disorders (1) (1).pdf
15333964-Immunodeficiency-Disorders (1) (1).pdf15333964-Immunodeficiency-Disorders (1) (1).pdf
15333964-Immunodeficiency-Disorders (1) (1).pdf
 
Pathogenisis of aids
Pathogenisis of aidsPathogenisis of aids
Pathogenisis of aids
 
Tutorial secondary idd aids
Tutorial secondary idd aids Tutorial secondary idd aids
Tutorial secondary idd aids
 
Human Immunodeficiency Virus
Human Immunodeficiency VirusHuman Immunodeficiency Virus
Human Immunodeficiency Virus
 
Hiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikalHiv infection-and-aids dr bikal
Hiv infection-and-aids dr bikal
 
Hiv aids
Hiv aidsHiv aids
Hiv aids
 
Human inmunodefinciency virus
Human inmunodefinciency virus Human inmunodefinciency virus
Human inmunodefinciency virus
 
Hiv infection by ved
Hiv infection by vedHiv infection by ved
Hiv infection by ved
 
HIV
HIVHIV
HIV
 
About human immunodeficiency virus (HIV)
About  human immunodeficiency virus (HIV)About  human immunodeficiency virus (HIV)
About human immunodeficiency virus (HIV)
 
Acquired immunodeficiency syndrome.pptx
Acquired immunodeficiency  syndrome.pptxAcquired immunodeficiency  syndrome.pptx
Acquired immunodeficiency syndrome.pptx
 
HIV infection. HIV-associated related opportunistic infections and invasions
HIV infection. HIV-associated related opportunistic infections and invasionsHIV infection. HIV-associated related opportunistic infections and invasions
HIV infection. HIV-associated related opportunistic infections and invasions
 
AIDS.pptx
AIDS.pptxAIDS.pptx
AIDS.pptx
 
2.HIV infections.ppt
2.HIV infections.ppt2.HIV infections.ppt
2.HIV infections.ppt
 
Hiv infection
Hiv  infectionHiv  infection
Hiv infection
 
Microbiology of HIV VIRUSES
Microbiology of HIV VIRUSESMicrobiology of HIV VIRUSES
Microbiology of HIV VIRUSES
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Human retroviruses
Human retroviruses Human retroviruses
Human retroviruses
 
Hiv and oppurtunistic infections
Hiv and oppurtunistic infectionsHiv and oppurtunistic infections
Hiv and oppurtunistic infections
 

Mehr von Forensic Pathology (20)

Stat3 central tendency & dispersion
Stat3 central tendency & dispersionStat3 central tendency & dispersion
Stat3 central tendency & dispersion
 
Exercise 1 12 no solution
Exercise 1 12 no solutionExercise 1 12 no solution
Exercise 1 12 no solution
 
Writing a research protocol 2011
Writing a research protocol 2011Writing a research protocol 2011
Writing a research protocol 2011
 
Some statistical defenition
Some statistical defenitionSome statistical defenition
Some statistical defenition
 
Prac excises 3[1].5
Prac excises 3[1].5Prac excises 3[1].5
Prac excises 3[1].5
 
Exercise 1 12 no solution
Exercise 1 12 no solutionExercise 1 12 no solution
Exercise 1 12 no solution
 
Analysis of variance
Analysis of varianceAnalysis of variance
Analysis of variance
 
Stat6 chi square test
Stat6 chi square testStat6 chi square test
Stat6 chi square test
 
Stat5 the t test
Stat5 the t testStat5 the t test
Stat5 the t test
 
Stat3 central tendency & dispersion
Stat3 central tendency & dispersionStat3 central tendency & dispersion
Stat3 central tendency & dispersion
 
Stat 4 the normal distribution & steps of testing hypothesis
Stat 4 the normal distribution & steps of testing hypothesisStat 4 the normal distribution & steps of testing hypothesis
Stat 4 the normal distribution & steps of testing hypothesis
 
Stat 2 data presentation2
Stat 2 data presentation2Stat 2 data presentation2
Stat 2 data presentation2
 
Correlation 3rd
Correlation 3rdCorrelation 3rd
Correlation 3rd
 
Stat 1 variables & sampling
Stat 1 variables & samplingStat 1 variables & sampling
Stat 1 variables & sampling
 
Pancreas 2
Pancreas 2Pancreas 2
Pancreas 2
 
Pancreas 1
Pancreas 1Pancreas 1
Pancreas 1
 
Liver 3
Liver 3Liver 3
Liver 3
 
Liver 2
Liver 2Liver 2
Liver 2
 
Liver 1
Liver 1Liver 1
Liver 1
 
The biliary tract
The biliary tractThe biliary tract
The biliary tract
 

Immunopathology 5

  • 2.  may arise as complications of :- infections ; malnutrition ; aging ; or side effects of immunosuppression, irradiation , chemotherapy. Acquired Immunodeficiency Syndrome (AIDS) :  caused by retrovirus Human Immunodeficiency Virus (HIV).  characterized by profound immunosuppression that leads to opportunistic infections, secondary neoplasms, and neurologic manifestations.
  • 3.  The virus is transmited via: 1. Unprotected sex with someone who is infected. 2. Transfusion of contaminated blood or blood products ; skin grafts or organ transplants taken from someone who is infected. 3. From a mother who is infected to her baby , this can occur during pregnancy, at birth , and through breast feeding. 4. Sharing unsterilized injection equipment that has previously been used by someone who is infected as in drug addicts.
  • 4. Properties of HIV:  HIV is retrovirus ( RNA containing virus ) that can convert its genetic material into DNA by means of enzyme reverse transcriptase which enables it to become integrated into DNA of its host cells.  Two genetically different but related forms of HIV, called HIV-1 and HIV-2. Structure of HIV:  HIV virion is spherical and contains a cone-shaped core surrounded by a lipid envelope derived from the host cell membrane .
  • 5.  The virus core contains: (1) major capsid protein ( p24 ). (2) nucleocapsid protein ( p7/p9 ). (3) two copies of genomic RNA. (4) three viral enzymes (protease , reverse transcriptase , and integrase).
  • 6.  p24 is the most readily detected viral antigen and, is the target for antibodies that are used for diagnosis of HIV infection.  The viral core is surrounded by a matrix protein called p17, which lies underneath the virion envelope.  Studding the viral envelope are two viral glycoproteins ( gp120 and gp41 ) which are critical for HIV infection of cells.
  • 8. Pathogenesis of HIV Infection and AIDS: there are two major targets of HIV infection: immune system and central nervous system. Immune system:-  This results from infection and severe loss of CD4+ T cells as well as impairment in function of surviving CD4+ T cells.  macrophages and dendritic cells are also targets of HIV infection.  HIV envelope contains two glycoproteins, surface ( gp120 ) that is non-covalently attached to transmembrane protein ( gp41 ).
  • 9.  The initial step in infection is binding of gp120.  This binding leads to a conformational change that results in formation of a new recognition site on gp120 for coreceptors CCR5 ( on macrophage ) or CXCR4 (on CD4+ T cells ).  The next step involves conformational changes in gp41 , these changes result in insertion of a fusion peptide at tip of gp41 into cell membrane of target cells .  After fusion, the virus core containing HIV genome enters cytoplasm of cell.
  • 10.  Once internalized, the RNA genome of virus undergoes reverse transcription, leading to formation of cDNA (proviral DNA) .  In quiescent T cells, HIV cDNA may remain in cytoplasm.  In dividing T cells, the cDNA , enters the nucleus and is then integrated into host genome.  After this integration, the provirus may remain locked into chromosome for months or years, and hence the infection becomes latent.  Alternatively, proviral DNA may be transcribed, with formation of complete viral particles that bud from cell membrane.
  • 11.  Such productive infection, when associated with extensive viral budding, leads to cell death.  Early in course of HIV infection, the immune system can replace the dying T cells.  Later in course of disease, renewal of CD4+ T cells cannot keep up with loss of these cells.  Despite the fact that macrophages allow viral replication, they are quite resistant to cytopathic effects of HIV, in contrast to CD4+ T cells. Thus, macrophages may be reservoirs of infection.
  • 12.  two types of dendritic cells are also targets of HIV infection: mucosal and follicular dendritic cells.  patients with AIDS also display profound abnormalities of B-cell function Central Nervous System:  It is a major target of HIV infection.  Macrophages and microglia (cells in central nervous system that belong to monocyte and macrophage lineage) are predominant cell types in brain that are infected with HIV.  HIV is carried into brain by infected monocytes.
  • 13. Natural History of HIV Infection: Three phases recognized:- (1) Early , acute retroviral syndrome. (2) Middle, chronic phase. (3) Final , full-blown AIDS.  Early , acute retroviral syndrome ( phase 1):  high level of virus production, viremia, and widespread seeding of lymphoid tissues.  however, is readily controlled by development of antiviral immune response.  Clinically: nonspecific symptoms, including sore throat, myalgia , fever, rash, weight loss, and fatigue, resembling a flulike syndrome.
  • 14. Middle chronic phase ( phase 2 ):  represents a stage of relative containment of virus, associated with period of clinical latency.  The immune system is largely intact, but there is continuous HIV replication, predominantly in lymphoid tissues, which may last for several years.  Patients are either asymptomatic or develop persistent generalized lymphadenopathy.
  • 15.  Final phase ( phase 3 ), full-blown AIDS :  Its progression to AIDS, characterized by a breakdown of host defense, a dramatic increase in plasma virus, and clinical disease.  Typically the patient presents with long-lasting fever (>1 month), fatigue, weight loss, and diarrhea.  After a variable period: serious opportunistic infections, secondary neoplasms, or clinical neurologic disease (grouped under the AIDS indicator diseases ), and the patient is said to have developed AIDS.
  • 16. Clinical Features of AIDS:  Opportunistic infections:  account for the majority of deaths in patients with AIDS.  Approximately 15% to 30% of HIV-infected people develop pneumonia caused by opportunistic fungus P. carinii .The risk of developing this infection is extremely high in individuals with fewer than 200 CD4+ cells/µL.  other opportunistic infections are caused by Candida, cytomegalovirus, atypical and typical mycobacteria, Cryptococcus neoformans, Toxoplasma gondii, and herpes simplex virus.
  • 17.  Neoplasms :  Kaposi sarcoma (KS) ; non-Hodgkin B-cell lymphoma ; cervical cancer in women ; and anal cancer in men.  It is estimated that 25% to 40% of HIV-infected individuals will eventually develop malignancy.  KS is composed of mesenchymal (spindle) cells that form blood vessels; the proliferation of these cells is driven by a variety of cytokines and growth factors that are derived from tumor cells , and from HIV-infected T cells. it is strongly linked to infection of tumor cells by KS-associated herpesvirus (KSHV).
  • 18.  Central nervous system:  90%of patients demonstrate some form of neurologic involvement at autopsy ; and 40% to 60% have clinically manifest neurologic dysfunction.  These include : self-limited meningoencephalitis ; aseptic meningitis ; vacuolar myelopathy ; peripheral neuropathies ; and most commonly a progressive encephalopathy designated clinically as (AIDS-dementia complex ).
  • 19. Morphology:  Biopsy specimens from enlarged lymph nodes in early stages of HIV infection reveal marked follicular hyperplasia.  With disease progression, B-cell proliferation subsides and gives rise to severe follicular involution. The follicles are depleted of cells. The germinal centers may become hyalinized. These lymph nodes are atrophic and small and may harbor numerous opportunistic pathogens.  Lymphoid depletion is not confined to lymph nodes; in later stages of AIDS, the spleen and thymus also appear to be "wastelands."